PCI, stent technology, dual antiplatelet therapy strategy, and coronary revascularisation trials covered in The Rhythm.
Coronary Intervention
Issue 16 | Week of 20 July 2026 A quiet week on the conference calendar, but not a quiet one in the journals. Five papers this week span antithrombotic strategy, a novel mechanistic approach in hypertrophic cardiomyopathy (HCM), population-level prevention, and the accuracy of lipid measurement. Cardiology Intelligence Briefing: precision
Coronary Intervention
Issue 11 | Week of 15 June 2026 No major cardiology congress fell this week. The most consequential evidence arrived through journal publication, and a single thread ran through it: a treatment can be mechanistically sound, biologically attractive, or statistically associated with benefit, and still fail when it is tested properly.
Atrial Fibrillation
Issue 10 | Week of 8 June 2026 No major cardiology congress fell this week. The European Renal Association (ERA) Congress in Glasgow, from 3 to 6 June, set the agenda, with the strongest cardiorenal evidence published simultaneously in JAMA and The Lancet. Cardiology Intelligence Briefing: where evidence stops Cardiovascular medicine
Coronary Intervention
Issue 8 | Week of 25 May 2026 EuroPCR took place in Paris from 19 to 22 May, dominating this week's evidence with three simultaneous publications across Circulation and EuroIntervention. Cardiology Intelligence Briefing: refining what we already do The five papers this week ask a narrower but increasingly important
Coronary Intervention
Issue 2 | Week of 13 April 2026 ACC.26 produced the most concentrated wave of practice-changing cardiology evidence so far this year. With landmark trials still being digested from the conference, this issue covers five more key papers from ACC.26, each with important implications for clinical decision-making.
Cardiology
The week's most important cardiology evidence, with an honest assessment of what should and shouldn't change your practice.